Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections (EMERON)
This study has been completed.
Study NCT00668122   Information provided by Bayer
First Received: April 24, 2008   Last Updated: June 29, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Urinary Tract Infection
Additional conditions recognized in this trial
Communicable Diseases
Infection
Urinary Tract Infections
More general conditions related to this trial
Urologic Diseases
Interventions listed in this trial
Cipro XR (Ciprofloxacin, BAYQ3939)
Cipro IR (Ciprofloxacin, BAYQ3939)
Additional drug interventions recognized in this trial
Ciprofloxacin
More general drug interventions related to this trial
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services